Literature DB >> 23855553

Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children.

Agnes Hamzaoui1, Anissa Berraies, Wajih Kaabachi, Maalmi Haifa, Jamel Ammar, Hamzaoui Kamel.   

Abstract

OBJECTIVE: Interleukin-33 is an IL-1 family cytokine which signals via its T1/ST2 receptor, and acts as a key regulator of inflammation, notably the type-2 response implicated in asthma. This study aims to measure the expression of soluble ST2 (sST2) and IL-33 in asthmatic children, depending on disease activity.
METHODS: Thirty-seven children with well-defined asthma (20 moderate and 17 mild asthmatics) were studied. IL-33 and sST2 were measured by ELISA in serum and induced sputum (IS) samples, and compared with 22 age- and sex-matched healthy controls. Real-time quantitative PCR was used to determine IL-33 and TNF-α mRNA expression in IS.
RESULTS: sST2 and IL-33 levels in IS and serum were significantly higher in patients compared with healthy controls (p = 0.0001). The increase in sST2 and IL33 was significantly more important in moderate cases than in mild asthma. A significant correlation was observed between serum and IS IL-33 levels (r = 0.497; p = 0.0018). Higher levels of IL-33 mRNA were detected in IS from asthmatics than those observed in controls. A significant correlation was found between TNF-α and IL-33 mRNA expression in the asthmatic subjects (r = 0.772, p = 0.0001).
CONCLUSIONS: Values of sST2 and IL-33 observed in IS were found to correlate with disease activity. Elevated IL-33 mRNA expression in IS and its correlation with TNF-α reflected the inflammatory process observed in the lung of young asthmatics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23855553     DOI: 10.3109/02770903.2013.816317

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  20 in total

1.  Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

Authors:  Ge Peng; Zhenzhen Mu; Lixia Cui; Pengyue Liu; Ying Wang; Wenqing Wu; Xiuping Han
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

2.  Tollip Inhibits ST2 Signaling in Airway Epithelial Cells Exposed to Type 2 Cytokines and Rhinovirus.

Authors:  Azzeddine Dakhama; Reem Al Mubarak; Nicole Pavelka; Dennis Voelker; Max Seibold; Julie G Ledford; Monica Kraft; Liwu Li; Hong Wei Chu
Journal:  J Innate Immun       Date:  2019-03-29       Impact factor: 7.349

3.  Defining the roles of IL-33, thymic stromal lymphopoietin, and IL-25 in human asthma.

Authors:  Derek E Byers
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

4.  IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells.

Authors:  David E Ochayon; Ayad Ali; Pablo C Alarcon; Durga Krishnamurthy; Leah C Kottyan; Michael T Borchers; Stephen N Waggoner
Journal:  J Leukoc Biol       Date:  2020-02-04       Impact factor: 4.962

Review 5.  IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies.

Authors:  Chantal Donovan; Philip M Hansbro
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-20

6.  Interleukin-33 and receptor ST2 as indicators in patients with asthma: a meta-analysis.

Authors:  Rui Li; Gang Yang; Ruiqi Yang; Xiaoxing Peng; Jing Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Bone marrow type 2 innate lymphoid cells: a local source of interleukin-5 in interleukin-33-driven eosinophilia.

Authors:  Kristina Johansson; Carina Malmhäll; Patricia Ramos-Ramírez; Madeleine Rådinger
Journal:  Immunology       Date:  2017-10-19       Impact factor: 7.397

Review 8.  IL-33: biological properties, functions, and roles in airway disease.

Authors:  Li Yin Drake; Hirohito Kita
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

9.  Signaling through FcRγ-associated receptors on dendritic cells drives IL-33-dependent TH2-type responses.

Authors:  Melissa Y Tjota; Cara L Hrusch; Kelly M Blaine; Jesse W Williams; Nora A Barrett; Anne I Sperling
Journal:  J Allergy Clin Immunol       Date:  2014-07-31       Impact factor: 10.793

10.  IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells.

Authors:  T Tanabe; T Shimokawaji; S Kanoh; B K Rubin
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.